Healthy control group:COVID-19 vaccine

2 trials

Sponsors

Second Affiliated Hospital of Chongqing Medical University

Conditions

Chronic hepatitis B virus (HBV) infectionChronic liver disease

Early Phase 1

Safety and immune response of COVID-19 vaccination in patients with chronic hepatitis B virus infection

Active, not recruitingChiCTR2100047936

Second Affiliated Hospital of Chongqing Medical UniversityChronic hepatitis B virus (HBV) infection

Start: 2021-07-01Updated: 2022-03-07

Study on the safety and efficacy of new crown vaccine in patients with chronic liver disease

RecruitingChiCTR2100049657

Second Affiliated Hospital of Chongqing Medical UniversityChronic liver disease

Start: 2021-07-31Updated: 2022-04-19